Subendocardial ischemia and myocarditis in systemic lupus erythematosus detected by cardiac magnetic resonance imaging.
Pavel
P
Goykhman
Puja K
PK
Mehta
Margo
M
Minissian
Louise E J
LE
Thomson
Daniel S
DS
Berman
Mariko L
ML
Ishimori
Daniel J
DJ
Wallace
Michael H
MH
Weisman
Chrisandra L
CL
Shufelt
C Noel
CN
Bairey Merz
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001562:Benzimidazoles / Q000627:therapeutic use; D001713:Biphenyl Compounds; D002637:Chest Pain / Q000175:diagnosis / Q000000981:diagnostic imaging; D017023:Coronary Angiography; D003331:Coronary Vessels / Q000187:drug effects / Q000503:physiopathology; D004699:Endocardium / Q000187:drug effects / Q000503:physiopathology*; D005260:Female; D006801:Humans; D006886:Hydroxychloroquine / Q000627:therapeutic use; D007511:Ischemia / Q000188:drug therapy / Q000209:etiology* / Q000503:physiopathology; D008180:Lupus Erythematosus, Systemic / Q000150:complications* / Q000188:drug therapy; D008279:Magnetic Resonance Imaging / Q000379:methods*; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D009205:Myocarditis / Q000175:diagnosis* / Q000000981:diagnostic imaging / Q000209:etiology*; D013777:Tetrazoles / Q000627:therapeutic use; D016896:Treatment Outcome
D000893:Anti-Inflammatory Agents; D001562:Benzimidazoles; D001713:Biphenyl Compounds; D013777:Tetrazoles; D006886:Hydroxychloroquine; C081643:candesartan; D008775:Methylprednisolone